American Century Companies’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-170,918
Closed -$1.41M 1483
2015
Q1
$1.41M Buy
170,918
+22,949
+16% +$170K ﹤0.01% 1097
2014
Q4
$1.02M Buy
147,969
+7,265
+5% +$45.4K ﹤0.01% 1185
2014
Q3
$760K Buy
140,704
+744
+0.5% +$4.34K ﹤0.01% 1227
2014
Q2
$892K Buy
+139,960
New +$963K ﹤0.01% 1239
2013
Q4
Sell
-921,159
Closed -$16.9M 1551
2013
Q3
$16.9M Buy
921,159
+896,430
+3,625% +$17.4M 0.02% 544
2013
Q2
$433K Buy
+24,729
New +$438K ﹤0.01% 1344

Other funds holding ARIA

American Century Companies's ARIA Position: Q2 2015 in Review

American Century Companies sold out of Ariad Pharmaceuticals Inc (ARIA) in Q2 2015, closing a stake of 170,918 shares — an estimated $1.41M sold.

American Century Companies first reported a position in ARIA in Q2 2013 and held it in 6 quarters. The position peaked at $16.9M in Q3 2013. 177 funds tracked by Wall St. Rank hold ARIA as of Q2 2015.

  • American Century Companies reported no remaining Ariad Pharmaceuticals Inc position as of Q2 2015 after selling out during the quarter.
  • American Century Companies sold 170,918 Ariad Pharmaceuticals Inc shares in Q2 2015, an estimated $1.41M.
  • American Century Companies first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 6 quarters.
  • American Century Companies's Ariad Pharmaceuticals Inc position peaked at $16.9M in Q3 2013.
  • 177 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2015.

Based on American Century Companies's 13F filing for Q2 2015, filed 28 Jul 2015.